Clinical Research Directory
Browse clinical research sites, groups, and studies.
UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes
Sponsor: Shanghai Changzheng Hospital
Summary
The aim is to investigate the safety and tolerability of intravenous infusion of allogeneic umbilical cord mesenchymal stem cells in pediatric patients diagnosed with newly onset type 1 diabetes
Official title: Investigation of Dose Escalation and Cohort Expansion Study on the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells(UCMSCs) Combined With Standard Therapy for Newly Diagnosed Type 1 Diabetes
Key Details
Gender
All
Age Range
8 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-05-23
Completion Date
2026-05-01
Last Updated
2024-12-27
Healthy Volunteers
Yes
Conditions
Interventions
UCMSCs
Peripheral intravenous infusion of umbilical cord mesenchymal stem cells
Placebo
Peripheral intravenous infusion of Placebo
Locations (1)
Shanghai Changzheng Hospital
Shanghai, Shanghai Municipality, China